WBA 📈 Walgreens Boots Alliance - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9314271084
WBA: Pharmacy, Health, Wellness, Beauty, Personal Care, General Merchandise
Walgreens Boots Alliance, Inc. is a multinational healthcare, pharmacy, and retail company with operations in the United States, Germany, the United Kingdom, and numerous international markets. The company's business is organized into three primary segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment is responsible for operating a vast network of retail drugstores across the United States, offering an extensive range of health and wellness services, including specialty pharmacy services and home delivery options. Additionally, this segment provides a broad selection of products such as beauty and personal care items, consumables, and general merchandise, catering to the diverse needs of its customers.
The International segment focuses on the sale of prescription drugs, health and wellness products, beauty and personal care items, and other consumer goods outside of the United States. This segment also oversees the operation of pharmacy-led health and beauty retail businesses under prominent brand names such as Boots in the United Kingdom, the Republic of Ireland, and Thailand, as well as Benavides in Mexico and Ahumada in Chile. These international operations enable Walgreens Boots Alliance to leverage its expertise and resources to deliver high-quality products and services to a global customer base. Furthermore, the company's international presence provides a platform for expansion into new markets and the development of strategic partnerships.
The U.S. Healthcare segment is a critical component of Walgreens Boots Alliance's business, providing a range of healthcare services and solutions through various subsidiaries. VillageMD, a national provider of value-based care, offers primary, multi-specialty, and urgent care services to patients in traditional clinic settings, as well as through in-home and online appointments. Shields, a specialty pharmacy integrator and accelerator, partners with hospitals to enhance their specialty pharmacy capabilities. CareCentrix, another key subsidiary, participates in the post-acute and home care management sectors, facilitating the delivery of high-quality, cost-effective care to patients in their homes. By offering these comprehensive healthcare services, Walgreens Boots Alliance is well-positioned to address the evolving needs of the healthcare industry and capitalize on emerging trends and opportunities.
With a rich history dating back to 1909, Walgreens Boots Alliance, Inc. has established itself as a leading player in the global healthcare, pharmacy, and retail landscape. Headquartered in Deerfield, Illinois, the company is committed to delivering innovative products, services, and solutions that enhance the lives of its customers and patients. As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol WBA, Walgreens Boots Alliance is dedicated to creating long-term value for its shareholders while maintaining its position as a trusted and respected leader in the healthcare industry. The company's website, https://www.walgreensbootsalliance.com, provides detailed information on its business operations, products, and services, as well as its commitment to corporate social responsibility and sustainability. With its common stock listed under the ISIN US9314271084 and classified as a Drug Retail company within the GICS Sub Industry, Walgreens Boots Alliance is poised for continued growth and success in the years to come.
Additional Sources for WBA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WBA Stock Overview
Market Cap in USD | 7,401m |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
GiC Sub-Industry | Drug Retail |
IPO / Inception | 1985-07-01 |
WBA Stock Ratings
Growth 5y | -91.6% |
Fundamental | -37.9% |
Dividend | 62.2% |
Rel. Strength Industry | -551 |
Analysts | 2.89/5 |
Fair Price Momentum | 7.35 USD |
Fair Price DCF | - |
WBA Dividends
Dividend Yield 12m | 10.47% |
Yield on Cost 5y | 2.25% |
Annual Growth 5y | 1.34% |
Payout Consistency | 97.7% |
WBA Growth Ratios
Growth Correlation 3m | 33.4% |
Growth Correlation 12m | -94.1% |
Growth Correlation 5y | -75% |
CAGR 5y | -26.43% |
CAGR/Mean DD 5y | -0.77 |
Sharpe Ratio 12m | -1.59 |
Alpha | -80.07 |
Beta | 0.70 |
Volatility | 79.31% |
Current Volume | 24043k |
Average Volume 20d | 26857k |
As of December 22, 2024, the stock is trading at USD 9.55 with a total of 24,042,965 shares traded.
Over the past week, the price has changed by -3.91%, over one month by +12.79%, over three months by +7.28% and over the past year by -61.14%.
Probably not. Based on ValueRay Fundamental Analyses, Walgreens Boots Alliance (NASDAQ:WBA) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.93 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WBA as of December 2024 is 7.35. This means that WBA is currently overvalued and has a potential downside of -23.04%.
Walgreens Boots Alliance has received a consensus analysts rating of 2.89. Therefor, it is recommend to hold WBA.
- Strong Buy: 1
- Buy: 2
- Hold: 12
- Sell: 2
- Strong Sell: 2
According to ValueRays Forecast Model, WBA Walgreens Boots Alliance will be worth about 7.9 in December 2025. The stock is currently trading at 9.55. This means that the stock has a potential downside of -16.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.6 | 11% |
Analysts Target Price | 26.1 | 173.4% |
ValueRay Target Price | 7.9 | -16.9% |